Detalhe da pesquisa
1.
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep
; 73(4): 77-83, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300853
2.
Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023.
MMWR Morb Mortal Wkly Rep
; 72(5): 125-127, 2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730050
3.
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.
MMWR Morb Mortal Wkly Rep
; 72(24): 651-656, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319011
4.
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(6): 206-211, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143464